{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:54:15Z","timestamp":1768697655291,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.tox.2016.11.015","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T16:45:16Z","timestamp":1479919516000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats"],"prefix":"10.1016","volume":"374","author":[{"given":"Maibam Wanta","family":"Khuman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankaran Kutty","family":"Harikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Sadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manickam","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vattaparambil Sukumaran","family":"Susanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashree","family":"Parida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souvendra Nath","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.11.015_bib0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","article-title":"Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta","volume":"4","author":"Abreu","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tox.2016.11.015_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2016.05.015","article-title":"Sodium arsenite-induced myocardial bruise in rats: ameliorative effect of naringin via TGF-\u03b2\/Smad and Nrf\/HO pathways","volume":"253","author":"Adil","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2016.11.015_bib0015","first-page":"e774","article-title":"Vascular protective effects of angiotensin receptor blockers: beyond blood pressure","volume":"2","author":"Artham","year":"2015","journal-title":"Recept. Clin. Investig."},{"key":"10.1016\/j.tox.2016.11.015_bib0020","first-page":"85","article-title":"Candesartan cilexetil\/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)","volume":"7","author":"B\u00f6nner","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.tox.2016.11.015_bib0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.tox.2016.11.015_bib0030","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2016.11.015_bib0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.taap.2006.12.032","article-title":"Arsenic and diabetes and hypertension in human populations: a review","volume":"222","author":"Chen","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.11.015_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvs230","article-title":"Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome","volume":"96","author":"Chu","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tox.2016.11.015_bib0045","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.tox.2016.11.015_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tox.2016.11.015_bib0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3317\/jraas.2006.037","article-title":"Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II","volume":"7","author":"de las Heras","year":"2006","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.tox.2016.11.015_bib0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.11.015_bib0065","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tox.2016.11.015_bib0070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/HJH.0b013e3280149708","article-title":"Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection","volume":"25","author":"Elewa","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tox.2016.11.015_bib0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.115.223289","article-title":"Arsenic, reactive oxygen, and endothelial dysfunction","volume":"353","author":"Ellinsworth","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.11.015_bib0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2012.06.015","article-title":"Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice","volume":"300","author":"Fouad","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.11.015_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/znc-2015-5031","article-title":"Protective effect of telmisartan treatment against arsenic-induced testicular toxicity in rats","volume":"70","author":"Fouad","year":"2015","journal-title":"Z. Naturforsch C"},{"key":"10.1016\/j.tox.2016.11.015_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1527-3466.2004.tb00146.x","article-title":"Candesartan","volume":"22","author":"Gleiter","year":"2004","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.tox.2016.11.015_bib0095","series-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons","first-page":"45","article-title":"Mechanisms of toxicity","author":"Gregus","year":"2008"},{"key":"10.1016\/j.tox.2016.11.015_bib0100","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1080\/10934529.2012.680329","article-title":"Hypertension in chronic arsenic exposure: a case control study in West Bengal","volume":"47","author":"Guha Mazumder","year":"2012","journal-title":"J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng."},{"key":"10.1016\/j.tox.2016.11.015_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CGM.S14205","article-title":"TGF-\u03b2 mediated crosstalk between malignant hepatocyte and tumor microenvironment in hepatocellular carcinoma","volume":"7","author":"Gupta","year":"2014","journal-title":"Cancer Growth Metastasis."},{"key":"10.1016\/j.tox.2016.11.015_bib0110","series-title":"Guyton and Hall Textbook of Medical Physiology.","first-page":"220","author":"Hall","year":"2011"},{"key":"10.1016\/j.tox.2016.11.015_bib0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells","volume":"17","author":"Hayashida","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.tox.2016.11.015_bib0120","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","first-page":"721","article-title":"Renin and angiotensin","author":"Hilal-Dandan","year":"2011"},{"key":"10.1016\/j.tox.2016.11.015_bib0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2013.04.006","article-title":"Arsenic upregulates the expression of angiotensin II type I receptor in mouse aortic endothelial cells","volume":"220","author":"Hossain","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2016.11.015_bib0130","first-page":"S19","article-title":"Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers","volume":"11","author":"Hubner","year":"1997","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tox.2016.11.015_bib0135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.tox.2016.11.015_bib0140","first-page":"12","article-title":"A review on candesartan: pharmacological and pharmaceutical profile","volume":"1","author":"Husain","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.tox.2016.11.015_bib0145","first-page":"645","article-title":"Smad protein and TGF-beta signaling in vascular smooth muscle cells","volume":"11","author":"Ikedo","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.tox.2016.11.015_bib0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1357-2725(03)00255-3","article-title":"Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles","volume":"36","author":"Javelaud","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tox.2016.11.015_bib0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cbpc.2006.11.001","article-title":"Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats","volume":"144","author":"Kalia","year":"2007","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2016.11.015_bib0160","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2174\/1381612811319170009","article-title":"Angiotensin II blockade and renal protection","volume":"19","author":"Kobori","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tox.2016.11.015_bib0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","article-title":"Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients","volume":"42","author":"Koh","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2016.11.015_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/jpet.108.139618","article-title":"Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study","volume":"326","author":"Kozak","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.11.015_bib0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.taap.2007.04.003","article-title":"Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia","volume":"222","author":"Kwok","year":"2007","journal-title":"China. Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.11.015_bib0180","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1289\/ehp.8000","article-title":"Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle","volume":"113","author":"Lee","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2016.11.015_bib0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2016.11.015_bib0190","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massague","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.tox.2016.11.015_bib0195","doi-asserted-by":"crossref","first-page":"F278","DOI":"10.1152\/ajprenal.00139.2003","article-title":"Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1","volume":"286","author":"Naito","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tox.2016.11.015_bib0200","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature","volume":"19","author":"Nguyen","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tox.2016.11.015_bib0205","doi-asserted-by":"crossref","unstructured":"Odenbach, J., Wang, X., Cooper, S., Chow, F. L., Oka, T., Lopaschuk, G., Kassiri, Z., Fernandez-Patron, C., 2011. MMP-2 mediates angiotensin II\u2013induced hypertension under the transcriptional control of MMP-7 and TACE. Hypertension 57, 123\u2013130.","DOI":"10.1161\/HYPERTENSIONAHA.110.159525"},{"key":"10.1016\/j.tox.2016.11.015_bib0210","first-page":"684","article-title":"Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension","volume":"15","author":"Ogihara","year":"1993","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tox.2016.11.015_bib0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.09.019","article-title":"The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer","volume":"355","author":"Okazaki","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tox.2016.11.015_bib0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","article-title":"CCN proteins: multifunctional signalling regulators","volume":"363","author":"Perbal","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2016.11.015_bib0225","first-page":"R1719","article-title":"Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers","volume":"275","author":"Pollock","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2016.11.015_bib0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","article-title":"A simplified method for the analysis of hydroxyproline in biological tissues","volume":"29","author":"Reddy","year":"1996","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tox.2016.11.015_bib0235","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism","volume":"111","author":"Rodriguez-Vita","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.tox.2016.11.015_bib0240","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","article-title":"TGF-beta signaling in vascular fibrosis","volume":"74","author":"Ruiz-Ortega","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tox.2016.11.015_bib0245","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tox.2016.11.015_bib0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/0192623311432297","article-title":"Chronic low-level arsenite exposure through drinking water increases blood pressure and promotes concentric left ventricular hypertrophy in female mice","volume":"40","author":"Sanchez-Soria","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2016.11.015_bib0255","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tox.2016.11.015_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1573402052952834","article-title":"Extracellular matrix remodeling in hypertension","volume":"1","author":"Sasamura","year":"2005","journal-title":"Curr. Hypertens. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.tox.2016.11.015_bib0265","first-page":"S91","article-title":"Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker","volume":"11","author":"Sever","year":"1997","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.tox.2016.11.015_bib0270","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1289\/ehp.1103441","article-title":"Arsenic Toxicology: translating between experimental models and human pathology","volume":"119","author":"States","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2016.11.015_bib0275","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1440-1681.12137","article-title":"Protective arms of the renin-angiotensin-system in neurological disease","volume":"40","author":"Sumners","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tox.2016.11.015_bib0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/hr.2010.224","article-title":"Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats","volume":"34","author":"Takai","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tox.2016.11.015_bib0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.HYP.36.3.330","article-title":"Angiotensin II activates collagen I gene through a mechanism involving the MAP\/ER kinase pathway","volume":"36","author":"Tharaux","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.tox.2016.11.015_bib0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells","volume":"52","author":"Touyz","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tox.2016.11.015_bib0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cbi.2015.06.014","article-title":"Arsenic causes aortic dysfunction and systemic hypertension in rats: augmentation of angiotensin II signaling","volume":"237","author":"Waghe","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2016.11.015_bib0300","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.ATV.0000225777.58488.f2","article-title":"Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall","volume":"26","author":"Wang","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tox.2016.11.015_bib0305","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00204-012-0845-z","article-title":"Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-\u03baB, and MAPK pathways","volume":"86","author":"Wang","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.11.015_bib0310","doi-asserted-by":"crossref","first-page":"d1109","DOI":"10.2741\/1057","article-title":"The 26S proteasome system in the signaling pathways of TGF-beta superfamily","volume":"8","author":"Wang","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.tox.2016.11.015_bib0315","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.fct.2007.05.024","article-title":"Lifelong inorganic arsenic compounds consumption affected blood pressure in rats","volume":"45","author":"Yang","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2016.11.015_bib0320","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.HYP.33.4.961","article-title":"Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography","volume":"33","author":"Yoshiyama","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.tox.2016.11.015_bib0325","doi-asserted-by":"crossref","first-page":"e17437","DOI":"10.1371\/journal.pone.0017437","article-title":"Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats","volume":"6","author":"Yung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2016.11.015_bib0330","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.tox.2016.11.015_bib0335","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1470320310391503","article-title":"A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension","volume":"12","author":"Zheng","year":"2011","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.tox.2016.11.015_bib0340","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s40572-014-0024-x","article-title":"Arsenic and chronic kidney disease: a systematic review","volume":"1","author":"Zheng","year":"2014","journal-title":"Curr. Environ. Health Rep."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:34:06Z","timestamp":1759534446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16302943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":68,"alternative-id":["S0300483X16302943"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.11.015","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}